The results colic of these studies colic showed that use the antiangiogenic bevacizumab and chemoth

Technologies transport systems Chemical Engineering and Technology Electrical Engineering and Space Engineering colic Technology Computer Engineering Technology and Environmental Technology Food Technology Industrial Technology Materials Technology Technology and Mechanical Engineering Technology Energy Technology Metallurgical Technology Telecommunications Other technological fields BIOMEDICAL AND HEALTH
Clinical Epidemiology Science Medicine Internal Medicine Pathology Pharmacology job Psychiatry Public Health Preventive Toxicology Other medical specialties MATHEMATICS, PHYSICS AND CHEMISTRY colic Mathematics Physics Chemistry Astronomy and Astrophysics HUMANITIES Linguistic Sciences Arts and Humanities History Philosophy Science Ethics SOCIAL SCIENCE Information
The Spanish authorities colic support the use of a supplementary to chemotherapy for patients with advanced-stage ovarian cancer treatment. Bevacizumab drug used in the therapy of other types of tumors, blocks the creation of new blood vessels required for tumor development. Learn more about: cancer tumor chemotherapy drugs drugs
The National Health System has authorized the use of a biological drug for patients with advanced ovarian cancer. It is Bevacizumab (Avastin , trade name of Roche), an angiogenic therapy and approved in colorectal, breast, lung and kidney, which slows the vascularization of the tumor tissue by blocking a key factor in this process.
Angiogenesis induce the creation of new blood vessels that support tumor growth. When the size of the cancer beyond the millimeter needs to develop its own network of vessels colic that provide necessary nutrients.
According to spokesmen for Roche, who today introduced the use of the drug at a press conference, Spain around 3,000 new cases of ovarian cancer are diagnosed each year. In 75% of cases detected when the disease is already at an advanced stage. This is because there is an efficient and cost-effective screening.
"For patients in more advanced stages of the tumor, the treatment increases five to six months, during which time we control the disease," said at a press conference Antonio Gonzalez, president of the Spanish Group for Research in Ovarian Cancer colic (GEICO ).
GEICO had an active participation in the ICON7 trial, conducted by a network of researchers from the International Gynecologic colic Cancer Group (GCIG) of the Spanish group is part and included more than 1,500 patients with epithelial colic ovarian cancer who had not received treatment prior.
The results colic of these studies colic showed that use the antiangiogenic bevacizumab and chemotherapy in first line, and then continue treatment with antiangiogenic gets only increase progression-free survival time elapsed during and after treatment in which the cancer does not grow or spreads colic even more, compared to the use of chemotherapy alone.
Both experts agree that highlight the profile of the patient's benefit from the addition of bevacizumab, which reduces mortality by 22%, is one that has not received prior treatment and with more advanced disease stages, in stage III or IV, who have not had adequate surgery.
Ebola and spans three countries
AGENCY SYNC ON FACEBOOK
Accessibility Privacy Policy Disclaimer Powered by eZ Publish